We are live on ! Find out more

711 hedge funds and large institutions have $12.6B invested in Sanofi in 2024 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 298 increasing their positions, 203 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 298 | Existing positions reduced: 203

23% more call options, than puts

Call options by funds: $76.8M | Put options by funds: $62.4M

18% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 71

1% more funds holding

Funds holding: 707711 (+4)

0.19% more ownership

Funds ownership: 20.17%20.36% (+0.19%)

1% less capital invested

Capital invested by funds: $12.7B → $12.6B (-$133M)

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
711
Holders Change
+4
Holders Change %
+0.57%
% of All Funds
10.24%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
84
Increased
298
Reduced
203
Closed
71
Calls
$76.8M
Puts
$62.4M
Net Calls
+$14.3M
Net Calls Change
+$6.43M
Name Holding Trade Value Shares
Change
Change in
Stake
GIM
701
Gold Investment Management
Alberta, Canada
$1.46K
OC
702
Oakworth Capital
Alabama
$1.46K +$1.47K +30 New
SIS
703
Sound Income Strategies
Florida
$1.36K
CYG
704
Clean Yield Group
Vermont
$972 -$977 -20 -50%
TCM
705
TD Capital Management
Tennessee
$972
GAG
706
Goodman Advisory Group
Massachusetts
$486
NECFA
707
New England Capital Financial Advisors
Connecticut
$486
T
708
Tidemark
California
$389
MAWCM
709
Mine & Arao Wealth Creation & Management
California
$146 +$146 +3 New
Zurich Cantonal Bank
710
Zurich Cantonal Bank
Switzerland
$49 -$14.6K -299 -100%
Point72 Asset Management
711
Point72 Asset Management
Connecticut
-$38.1M -766,300 Closed
SI
712
Sofinnova Investments
California
-$29.8M -598,978 Closed
ITP
713
Iron Triangle Partners
Connecticut
-$24.9M -500,000 Closed
Adage Capital Partners
714
Adage Capital Partners
Massachusetts
-$22.4M -450,000 Closed
IHAM
715
Integral Health Asset Management
New York
-$19.9M -400,000 Closed
CCP
716
Clough Capital Partners
Massachusetts
-$16M -322,000 Closed
VPC
717
Vestal Point Capital
New York
-$14.9M -300,000 Closed
SCM
718
Silverarc Capital Management
Massachusetts
-$10.9M -220,000 Closed
GHA
719
GW Henssler & Associates
Georgia
-$7.58M -152,386 Closed
ECG
720
Edge Capital Group
Georgia
-$7.32M -147,281 Closed
Balyasny Asset Management
721
Balyasny Asset Management
Illinois
-$6.55M -131,715 Closed
VOYA Investment Management
722
VOYA Investment Management
Georgia
-$6.2M -124,640 Closed
OFA
723
Oak Family Advisors
Illinois
-$3.01M -60,621 Closed
Qube Research & Technologies (QRT)
724
Qube Research & Technologies (QRT)
United Kingdom
-$3.01M -60,581 Closed
Connor, Clark & Lunn Investment Management (CC&L)
725
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$2.17M -43,622 Closed

SNY Hedge Fund Activity: Q1 2024 in Review

711 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2024, worth a combined $12.6B — down 1% from $12.7B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new SNY positions and 71 closed out — a net gain of 13 holders — while 298 added to existing stakes and 203 trimmed.

The largest buyer was Barrow, Hanley, Mewhinney & Strauss, opening a new position worth an estimated $136M. The largest seller was Morgan Stanley, cutting an estimated $312M.

  • 711 institutional investors held Sanofi (SNY) as of Q1 2024, up from 707 in Q4 2023.
  • Funds reported $12.6B of Sanofi stock for Q1 2024, down 1% quarter-over-quarter.
  • 84 funds opened new Sanofi positions in Q1 2024 and 71 closed out, a net change of +13 holders.
  • The largest Sanofi buyer in Q1 2024 was Barrow, Hanley, Mewhinney & Strauss, an estimated $136M added.
  • The largest Sanofi seller in Q1 2024 was Morgan Stanley, an estimated $312M sold.

Based on aggregated 13F filings for Q1 2024.